KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
0.9000
+0.0013 (0.14%)
Aug 19, 2026, 4:00 PM EDT - Market closed
KALA BIO Employees
KALA BIO had 6 employees as of December 31, 2025. The number of employees decreased by 32 or -84.21% compared to the previous year.
Employees
6
Change (1Y)
-32
Growth (1Y)
-84.21%
Revenue / Employee
n/a
Profits / Employee
-$3,275,667
Market Cap
16.73M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 6 | -32 | -84.21% |
| Dec 31, 2024 | 38 | -5 | -11.63% |
| Dec 31, 2023 | 43 | 9 | 26.47% |
| Dec 31, 2022 | 34 | -158 | -82.29% |
| Dec 31, 2021 | 192 | 4 | 2.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Citius Pharmaceuticals | 23 |
| Lipocine | 14 |
| NewcelX | 12 |
| Tvardi Therapeutics | 12 |
| Psyence Biomedical | 12 |
| Akari Therapeutics, | 6 |
| Pasithea Therapeutics | 5 |
KALA News
- 21 hours ago - KALA BIO Quarterly report: Q2 2026 - Filings
- 2 months ago - KALA BIO Registration statement: Registration filing - Filings
- 3 months ago - KALA BIO Quarterly report: Q1 2026 - Filings
- 3 months ago - Kala Bio falls -21.7% - TheFly
- 3 months ago - Kala Bio files $350M mixed securities shelf - TheFly
- 3 months ago - Kala Bio announces reverse stock split - TheFly
- 3 months ago - KALA BIO Announces Reverse Stock Split - GlobeNewsWire
- 3 months ago - KALA BIO Registration statement: Registration filing - Filings